Has Yousef Zarbalian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,692 in general payments to Yousef Zarbalian, MD across 143 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yousef Zarbalian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yousef Zarbalian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yousef Zarbalian, MD

Rheumatology · Vienna, VANPI 1396063319

Payments from drug & device makers

$2,692in general payments, 2019–2025

Across 143 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$385
Mallinckrodt Enterprises LLC$284
Mallinckrodt Hospital Products Inc.$249
Johnson & Johnson$221
Bristol Myers Squibb$216
Novartis$190
plus $1K from 12 others

What the payments were for

Food & beverage$2,692100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	20	$385
Mallinckrodt Enterprises LLC	10	$284
Mallinckrodt Hospital Products Inc.	6	$249
Johnson & Johnson	13	$221
Bristol Myers Squibb	26	$216
Novartis	11	$190
UCB, Inc.	10	$175
Pfizer	10	$164
Genentech USA, Inc.	9	$160
E.r. Squibb & Sons, L.L.C.	7	$128
AstraZeneca	1	$122
AbbVie	5	$96
Radius Health, Inc.	4	$84
Lilly USA, LLC	4	$79
Regeneron Healthcare Solutions, Inc.	3	$61
GSK	2	$37
Sobi, Inc	1	$31
Actelion Pharmaceuticals US, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ACTHAR$122

How this compares

$2,692 in reported general payments places this provider in the 45th percentile of 159 rheumatology providers in Virginia.

See all rheumatology providers in Virginia →

Medicare billing

Part B allowed, 2024

$80,991

Medicare patients

Services billed

870

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclobenzaprine Hcl	11	$344
Hydroxychloroquine Sulfate	15	$317
Prednisone	28	$230
Levothyroxine Sodium	13	$152
Allopurinol	13	$71

Paid to pharmacies, not to this prescriber.

Other rheumatology in Vienna

Mahsa TehraniVienna$19K
Mahnaz MomeniVienna$15K
Peter LipskyCharlottesville$1.6M
Sharukh ShroffDanville$1.5M
Kristi MizelleNewport News$1.2M
Phillip KempfArlington$467K
Adegbenga BankoleRoanoke$355K
Michael StrachanRichmond$158K
Karim MasriRichmond$147K
Michael CannonVirginia Beach$145K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →